Semler Reports Third Quarter and Year-to-Date 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- S&P 500 flat as higher bond yields counter tech optimism
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
- Salesforce agrees to acquire AI research platform Listen Labs
- Workday cuts 2.5% of workforce, revises GAAP margin outlook
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Stocks fall as higher oil prices, Treasury yields weigh
Semler Scientific (SMLR) Tops Q2 EPS by 4c
October 26, 2018 8:06 AM EDTSemler Scientific (SMLR) reported Q2 EPS of $0.19, $0.04 better than the analyst estimate of $0.15. Revenue for the quarter came in at $5.58 million versus the consensus estimate of $5.7 million.
"It is our intent to provide cost efficient and practical means for our customers to better care for their patients," said Doug... More
